DexCom, Inc. (ETR:DC4)

Market Cap	29.53B
Revenue (ttm)	3.84B
Net Income (ttm)	495.17M
Shares Out	n/a
EPS (ttm)	1.23
PE Ratio	59.63
Forward PE	39.19
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80
Average Volume	259
Open	69.00
Previous Close	69.06
Day's Range	69.00 - 69.50
52-Week Range	52.00 - 108.58
Beta	n/a
RSI	39.82
Earnings Date	Jul 24, 2025

About DexCom

DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians. Its products include Dexcom G6 and Dexcom G7, integrated CGM systems for diabetes management; Dexcom Share, a remote monitoring system; Dexcom Real-Time API, which enables authorized third-party software developers to integrate real-time...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1999
• Employees: 10,300
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: DC4

Financial Performance

In 2024, DexCom's revenue was $4.03 billion, an increase of 11.34% compared to the previous year's $3.62 billion. Earnings were $576.20 million, an increase of 6.41%.

Financial numbers in USD